Cutting-Edge Diagnostic Technologies in Cardiovascular Diseases
197,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
99 °P sammeln
  • Gebundenes Buch

This book provides a comprehensive overview of cutting-edge technologies in the diagnosis of multiple cardiovascular disease. Readers will understand technical advancements and research gaps, which will help them to optimize the design of algorithms and devices.

Andere Kunden interessierten sich auch für
Produktbeschreibung
This book provides a comprehensive overview of cutting-edge technologies in the diagnosis of multiple cardiovascular disease. Readers will understand technical advancements and research gaps, which will help them to optimize the design of algorithms and devices.
Autorenporträt
Haipeng Liu received his Bachelor and Master in Engineering degrees from Zhejiang University, China, in 2012 and 2015, respectively, and Doctor of Philosophy in Medical Sciences from the Chinese University of Hong Kong, in 2018. From 2019 to 2024, he was a research fellow in Anglia Ruskin University and Coventry University, UK. He is currently an assistant professor at Coventry University. He is the author of over 90 journal articles, 11 conference papers, and 23 book chapters. Dr Liu is an editor of four academic books and seven special issues, and an editorial member of four scientific journals. His research interests include biomechanics, physiological measurement, and computational simulation of cardiovascular diseases. Dr. Liu was a recipient of two Travel Awards of British Heart Foundation, the Research and Innovation Support Fund of Anglia Ruskin University, and the Official Development Assistance (ODA) Fund of Coventry University. Gary Tse completed his pre-clinical training at Trinity Hall, Cambridge (2008), and was subsequently awarded a Doctor of Philosophy (Ph.D.) degree in Cardiac Electrophysiology (2015) and a Doctor of Medicine (M.D.) degree in Cardiovascular Epidemiology (2022) from the University of Cambridge. He was elected a fellow of the European Society of Cardiology (2016), American College of Cardiology (2017), Heart Rhythm Society (2018), Royal College of Physicians of London (2019), Royal College of Paediatrics and Child Health (2019), and Royal College of Pathologists (2022). Currently, he leads a team of researchers from China (Tianjin, Hong Kong) and the UK (Kent, Surrey, and London) focusing on the use of big data for cardiovascular risk prediction. He serves on the Council of the International Society of Electrocardiology, for which he is currently the Secretary. He is a Board of Trustees member of the International Society for Noninvasive Electrocardiology and a Nucleus Committee member of the Population Health Section, European Association of Preventive Cardiology.